N@N

Market Maker Surveillance Report. KO, PFE, BSX, AMGN, WFR, QQQ, Highest Net Buy Volume With Lowest Price Friction For Tuesday,

January 29, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3987 companies with "abnormal" market making, 3084 companies with positive Friction Factors and 2335 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Tuesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. The Coca-Cola Co (NYSE:KO), Pfizer Inc (NYSE:PFE), Boston Scientific Corp (NYSE:BSX), Amgen Inc (NASDAQ:AMGN), MEMC Electronic Materials Inc (NYSE:WFR), Powershares Qqq Trust Series 1 (NASDAQ:QQQ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  KO      $0.300    0.01%     6,914,510    39.40%    4,487,026    25.57%    2,427,484    80,916  
  PFE     $0.910    0.03%     17,700,470   24.57%    15,719,371   21.82%    1,981,099    21,770  
  BSX     $0.210    0.03%     22,450,259   31.93%    20,342,485   28.93%    2,107,774    100,370 
  AMGN    $1.000    0.01%     8,842,705    41.73%    6,604,590    31.17%    2,238,115    22,381  
  WFR     $0.040    0.01%     4,987,711    54.58%    1,608,322    17.60%    3,379,389    844,847 
  QQQ     $0.150    0.00%     18,407,402   56.03%    14,018,497   42.67%    4,388,905    292,594 

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar gains (Change) and very low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows KO with a Net Buy Volume of 2,427,484 shares and a Friction Factor of 80,916 shares. That means that it takes 80,916 more shares of buying than selling to move KO higher by one penny. This means the Market Makers are allowing the stock to move up higher as of Tuesday (lower friction). And with one of the highest Net Buy Volumes, the combination of low friction and high net buy volume is bullish.

The Coca-Cola Co (NYSE:KO) - The Coca-Cola Company, a beverage company, engages in the manufacture, marketing, and sale of nonalcoholic beverages worldwide. The company primarily offers sparkling beverages and still beverages. Its sparkling beverages include nonalcoholic ready-to-drink beverages with carbonation, such as carbonated energy drinks, and carbonated waters and flavored waters. The company s still beverages comprise nonalcoholic beverages without carbonation, such as noncarbonated waters, flavored waters and enhanced waters, noncarbonated energy drinks, juices and juice drinks, ready-to-drink teas and coffees, and sports drinks. It also provides flavoring ingredients, sweeteners, powders for purified water products, beverage ingredients, and fountain syrups. The Coca-Cola Company sells its products primarily under the Diet Coke, Fanta, Sprite, Coca-Cola Zero, vitaminwater, Powerade, Minute Maid, Simply, Georgia, and Del Valle brand names. The company offers its beverage products through company-owned or controlled bottling and distribution operators, as well as through independently owned bottling partners, distributors, wholesalers, and retailers. The Coca-Cola Company was founded in 1886 and is headquartered in Atlanta, Georgia..

Pfizer Inc (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and sale of medicines for people and animals worldwide. It primarily offers Celebrex, Chantix/Champix, Lipitor, Lyrica, Premarin, Pristiq, and Viagra pharmaceutical products in the therapeutic and disease areas of Alzheimer s disease, cardiovascular, erectile dysfunction, genitourinary, depressive disorder, pain, respiratory, and smoking cessation. The company also provides BeneFIX, Enbrel, Genotropin, Geodon, Prevnar/Prevenar, Rebif, ReFacto AF, Revatio, Xalatan, Xyntha, and Zyvox pharmaceutical products in the therapeutic and disease areas of anti-infectives, endocrine disorders, hemophilia, inflammation, multiple sclerosis, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines. In addition, it offers Aromasin, Sutent, Torisel, and Xalkori pharmaceutical products for addressing oncology and oncology-related illnesses; and other prescription pharmaceutical products, such as Arthrotec, Effexor, Medrol, Norvasc, Protonix, Relpax, and Zosyn/Tazocin. Further, the company provides vaccines, parasiticides, and anti-infectives to prevent and treat disease in livestock and companion animals; and non-prescription products, including Advil, Caltrate, Centrum, ChapStick, Preparation H, and Robitussin in the areas of dietary supplements, pain management, respiratory, and personal care. Additionally, it offers various infant and toddler nutritional products, such as S-26 and SMA product lines, as well as formula for infants with special nutritional needs. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York..

Boston Scientific Corp (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary revascularization products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator, and implantable pacemaker systems that monitor the heart and deliver electricity to treat cardiac abnormalities; endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to treat patients with peripheral diseases. In addition, the company offers devices comprising mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices to treat urinary stone disease, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding. Further, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Additionally, it offers implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; and implantable pacemaker systems used to manage slow or irregular heart rhythms. The company was founded in 1979 and is headquartered in Natick, Massachusetts..

Amgen Inc (NASDAQ:AMGN) - Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. Its principal products include Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is type of white blood cell that helps the body fight infections; Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body s response to inflammatory diseases; and Aranesp and EPOGEN erythropoiesis-stimulating agents, which stimulate the production of red blood cells. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production, as well as offers Prolia and XGEVA denosumab, which are human monoclonal antibodies that specifically targets RANKL, an essential regulator of osteoclasts. In addition, it provides product candidates in mid- to late-stage development in various therapeutic areas, such as oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine, which includes neuroscience. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products, as well as through the Internet. It has various collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; DaVita Inc.; Fresenius Medical Care North America; Cytokinetics, Inc.; Kirin-Amgen, Inc.; and AstraZeneca Plc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California..

MEMC Electronic Materials Inc (NYSE:WFR) - MEMC Electronic Materials, Inc. engages in the development, manufacture, and sale of silicon wafers for the semiconductor industry worldwide. The company operates in two segments, Semiconductor Materials and Solar Energy. The Semiconductor Materials segment offers prime polished wafers, such as OPTIA and annealed products; epitaxial wafers, including AEGIS that consists of a thin silicon layer grown on the polished surface of the wafer; test/monitor wafers for testing semiconductor fabrication lines and processes; and silicon-on-insulator wafers used in the chip making process. Its wafers are used as the starting material for the manufacture of various types of semiconductor devices, including microprocessor, memory, logic, and power devices. The Solar Energy segment provides solar energy services that integrate the design, installation, financing, monitoring, operation, and maintenance portions of the downstream solar market. This segment also manufactures polysilicon, silicon wafers, and solar modules. As of December 31, 2011, it interconnected approximately 580 solar power systems representing 600.4 megawatts of solar energy. In addition, the company develops and sells photovoltaic energy solutions. Its customers comprise semiconductor device manufacturers, including the memory, microprocessor, and ASIC manufacturers; and foundries, as well as national retail chains and real estate property management firms; federal, state, and municipal governments; and utilities. The company markets its solar energy generation, monitoring, and maintenance services through a direct sales force, as well as through local or regional solar channel partners. MEMC Electronic Materials, Inc. was founded in 1984 and is headquartered in St. Peters, Missouri..

Powershares Qqq Trust Series 1 (NASDAQ:QQQ) - .

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net